Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
64
NBIX Quote, Financials, Valuation and Earnings
Last price:
$145.16
Seasonality move
:
4.8%
Day range:
$144.65 - $146.79
52-week range:
$84.23 - $160.18
Dividend yield:
0%
P/E ratio:
34.69x
P/S ratio:
5.54x
P/B ratio:
4.82x
Volume:
693.8K
Avg. volume:
968.1K
1-year change:
4.48%
Market cap:
$14.5B
Revenue:
$2.4B
EPS (TTM):
$4.19
Neurocrine Biosciences, Inc. SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
NBIX
Neurocrine Biosciences, Inc.
|
05/01/2024 | 10-Q | 10-Q filing on 05/01/2024 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
10/31/2023 | 10-Q | 10-Q filing on 10/31/2023 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
08/01/2023 | 10-Q | 10-Q filing on 08/01/2023 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
05/03/2023 | 10-Q | 10-Q filing on 05/03/2023 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
11/01/2022 | 10-Q | 10-Q filing on 11/01/2022 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
08/04/2022 | 10-Q | 10-Q filing on 08/04/2022 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
05/04/2022 | 10-Q | 10-Q filing on 05/04/2022 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
11/01/2021 | 10-Q | 10-Q filing on 11/01/2021 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
08/03/2021 | 10-Q | 10-Q filing on 08/03/2021 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
05/05/2021 | 10-Q | 10-Q filing on 05/05/2021 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
11/09/2020 | 10-Q | 10-Q filing on 11/09/2020 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
08/03/2020 | 10-Q | 10-Q filing on 08/03/2020 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
05/06/2020 | 10-Q | 10-Q filing on 05/06/2020 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
02/07/2020 | 10-K | 10-K filing on 02/07/2020 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
11/04/2019 | 10-Q | 10-Q filing on 11/04/2019 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
07/29/2019 | 10-Q | 10-Q filing on 07/29/2019 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
04/29/2019 | 10-Q | 10-Q filing on 04/29/2019 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
02/08/2019 | 10-K | 10-K filing on 02/08/2019 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
11/05/2018 | 10-Q | 10-Q filing on 11/05/2018 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
07/31/2018 | 10-Q | 10-Q filing on 07/31/2018 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
04/30/2018 | 10-Q | 10-Q filing on 04/30/2018 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
02/13/2018 | 10-K | 10-K filing on 02/13/2018 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
11/01/2017 | 10-Q | 10-Q filing on 11/01/2017 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
08/03/2017 | 10-Q | 10-Q filing on 08/03/2017 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
05/09/2017 | 10-Q | 10-Q filing on 05/09/2017 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
02/14/2017 | 10-K | 10-K filing on 02/14/2017 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
11/02/2016 | 10-Q | 10-Q filing on 11/02/2016 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
08/03/2016 | 10-Q | 10-Q filing on 08/03/2016 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
05/05/2016 | 10-Q | 10-Q filing on 05/05/2016 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
04/29/2016 | 10-K | 10-K filing on 04/29/2016 | View Form |
|
NBIX
Neurocrine Biosciences, Inc.
|
02/11/2016 | 10-K | 10-K filing on 02/11/2016 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
